HealthcareMarketResearchReports

  Remdesivir Market Trends Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19 )  market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 )  market. According to MRFR analysis, Global  Remdesivir (COVID 19) Market  is expected to register a  CAGR of 31.2%  during the forecast period of 2020 to 2027 and reach  USD 10,119.99 Million by 2027. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipl...

  Artificial insemination Market Trends Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country. Global  Artificial insemination Market Trends  is expected to register a  CAGR of 8.56%  during the forecast period and is expected to hit  USD 3,409.75 Million by 2027 . The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycle...

  Catheter Securement Device Market Analysis Growing demand for catheter securement devices in minimally invasive surgeries and technological advancement is expected to register a  CAGR of ~8.2%  during the forecast period of 2021 to 2027 The global  Catheter Securement Device Market Analysis  is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period. Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global Catheter Securement Device Market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (...

  COVID Testing Kit Market Size According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth. Global  COVID Testing Kit Market Size  is expected to have a market value of  USD 97,903.2 Million  by 2027. Major Key Players: MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biote...

  Artificial Intelligence in Drug Discovery Market Size The growth of the global AI in Drug Discovery Market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. According to MRFR analysis, the Global  Artificial Intelligence in Drug Discovery Market Size   is expected to register a  CAGR of 40.8%  during the forecast period and is anticipated to reach  USD 2,015.1 Million by 2025. In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have ...

  Thalassemia Treatment Market Growth Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia. According to MRFR analysis,  Thalassemia Treatment Market Growth   is expected to register a  CAGR of 10.4%  during the forecast period and was valued at  USD 1890.4 Million in 2018. The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to ...

  Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. Healthcare Cyber Security Market Statistics  growth  is expected to register a  CAGR of   11.82%  during the forecast period, with a market value of  USD 16,393.15 Million till 2025. The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, fac...

  Uveitis Treatment Market Growth Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis. The growth of the global Uveitis Treatment Market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period. According to MRFR analysis,  Uveitis Treatment Market Growth   is expected to register a  CAGR of 5.6%  during the forecast period and was valued at  USD 534.6 million in 2018 . The global Uveitis Treatment Market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collab...

  Gene Therapy Market Forecast Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. According to MRFR analysis, the global  Gene Therapy Market Forecast  is expected to register a  CAGR of 40.7%  and was valued at USD 524 million in 2018. The growth of the global Gene Therapy Market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global Gene Therapy Market. The global Gene Therapy Market is currently dominated by several...

  Skin Tightening Market Insights According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US.  The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market. The Global  Skin Tightening Market Insights  is to be valued at  USD 6,340.99 Million  by 2025 with the  CAGR of 6.2%  during the forecast period. However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the Skin Tightening Market.   In the current scenario, several players are dominating the global Skin Tightening Market. The market leaders in skin tightening treatme...

  Durable Medical Equipment Market Outlook Durable Medical Equipment or home medical equipment provides therapeutic benefits to patients. They are easy to use and does not need any special skill or training thus can easily be managed by a caretaker or a family member of the patient. Increasing per capita income, healthcare expenditure and aging population in Middle East and Africa are driving the DME market’s growth. The Middle-East and Africa  Durable Medical Equipment Market Outlook  has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. The Middle East and Africa healthcare sector is growing by 10% annually and it comprise 2% of the total global healthcare expenditure. Huge Investment in R&D by DME manufacturers are leading to more innovative product development. Developing infrastructure, government initiatives, extended insurance coverage and increasing awareness are major drivers ...